XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
33.35
-1.45 (-4.15%)
At close: Oct 29, 2025, 4:00 PM EDT
33.35
+0.01 (0.01%)
After-hours: Oct 29, 2025, 5:20 PM EDT
XOMA Royalty Market Cap
XOMA Royalty has a market cap or net worth of $403.06 million as of October 29, 2025. Its market cap has increased by 24.83% in one year.
Market Cap
403.06M
Enterprise Value
433.79M
1-Year Change
24.83%
Ranking
Category
Stock Price
$33.35
Market Cap Chart
Since December 1, 1998, XOMA Royalty's market cap has increased from $151.40M to $403.06M, an increase of 166.23%. That is a compound annual growth rate of 3.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 420.50M | 35.82% |
| Dec 31, 2024 | 309.60M | 45.69% |
| Dec 29, 2023 | 212.50M | 0.85% |
| Dec 30, 2022 | 210.70M | -10.64% |
| Dec 31, 2021 | 235.80M | -51.52% |
| Dec 31, 2020 | 486.40M | 103.60% |
| Dec 31, 2019 | 238.90M | 125.16% |
| Dec 31, 2018 | 106.10M | -63.40% |
| Dec 29, 2017 | 289.90M | 1,036.86% |
| Dec 30, 2016 | 25.50M | -83.86% |
| Dec 31, 2015 | 158.00M | -59.01% |
| Dec 31, 2014 | 385.50M | -38.46% |
| Dec 31, 2013 | 626.40M | 220.08% |
| Dec 31, 2012 | 195.70M | 396.70% |
| Dec 30, 2011 | 39.40M | -64.76% |
| Dec 31, 2010 | 111.80M | -19.57% |
| Dec 31, 2009 | 139.00M | 69.31% |
| Dec 31, 2008 | 82.10M | -81.63% |
| Dec 31, 2007 | 447.00M | 100.18% |
| Dec 29, 2006 | 223.30M | 61.69% |
| Dec 30, 2005 | 138.10M | -37.68% |
| Dec 31, 2004 | 221.60M | -59.61% |
| Dec 31, 2003 | 548.60M | 84.40% |
| Dec 31, 2002 | 297.50M | -56.92% |
| Dec 31, 2001 | 690.50M | 7.32% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.71B |
| Johnson & Johnson | 454.18B |
| AbbVie | 403.09B |
| UnitedHealth Group | 332.65B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 222.97B |